VU Medical Center
Amsterdam, North Holland, 1081 HV, Netherlands
NCT Number: NCT02558166
This study consists of two substudies.
The first substudy:
'Renal resistive index in critically ill patients with cardiogenic and septic shock'
Design: cross-sectional observational
Aim of this project is:
1. to determine whether critically ill patients with cardiogenic and septic shock have an elevated Renal Resistive Index and 2. to determine whether Renal Resistive Index differs between cardiogenic/hypovolemic shock and shock due to sepsis/systemic inflammation (SIRS) 3. to determine the relation between the (change in) renal vascular resistance and
* Markers of the systemic - and the microcirculation * Fluid status as quantified by bioimpedance analysis * Concomitant renal function
The second substudy:
'Predictive value of the Renal Resistive Index on ICU admission and its course for the development of acute kidney injury in critically ill patients with cardiogenic and septic shock'
Design: longitudinal observational
The aim of this project is:
1. to determine whether the renal resistance index on admission to the intensive care unit can predict the development of acute kidney injury (AKI) in critically ill patients with shock 2. to investigate if the renal resistance index on admission to the intensive care unit is an independent predictor of the development of AKI or depends on the severity and duration of shock and other known risk factors of AKI such as comorbidity and use of nephrotoxic drugs
Aim of the large research project is to determine whether the Renal Resistive Index could become a monitoring tool for intervention studies aiming to prevent acute kidney injury or protect the kidney.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Amsterdam, North Holland, 1081 HV, Netherlands
Acute Kidney Injury (AKI) is a severe complication developing in intensive care patients as a result of hypovolemic, cardiogenic or septic shock. It is defined by an abrupt decrease in kidney function. It encompasses both direct injury to the kidney as well as acute impairment of function, including decreased glomerular filtration rate (GFR). Its prevention is crucial because AKI increases morbidity and mortality (1). Mechanisms comprise ischemia/reperfusion, oxidative stress, inflammation and toxicity (2).The common pathophysiological pathway includes endothelial damage to microvessels leading to impaired macro- and microvascular flow and this will aggravate ischemia (3).
Up to now, much controversy exists about
In this prospective observational study, three study measurement will be performed in two groups of critically ill patients (shock and no shock).
In addition, routinely measured markers of circulation, renal function and fluid balance will be collected for analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
First group (patients with shock):
Second group (patients without shock):
In both groups, written consent will be obtained if and when the patients are awake and able to communicate ('deferred consent')
Exclusion criteria
Time frame: 1 week
Time frame: 1 week
Amsterdam UMC, location VUmc
Other
Relation Between the Renal Resistive Index and Markers of the Systemic Circulation, the Microcirculation, Fluid Status and of Renal Function.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05931601
Cardiovascular Diseases, Disease Attributes
Copenhagen, Denmark
View Trial DetailsNCT07204899
Hypovolemic Shock, Nursing Education
Ankara, Turkey (Türkiye)
View Trial DetailsNCT04045327
Hypovolemic Shock, Pathologic Processes
Nagpur, Maha, India
View Trial DetailsNCT04056065
Blood Loss, Hemorrhage
Nagpur, Maha, India
View Trial Details